Literature DB >> 26254308

HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.

Mark S Borja1, Kit F Ng1, Angela Irwin2, Jaekyoung Hong3, Xing Wu3, Daniel Isquith3, Xue-Qiao Zhao3, Bryan Prazen4, Virginia Gildengorin1, Michael N Oda1, Tomáš Vaisar2.   

Abstract

HDL is the primary mediator of cholesterol mobilization from the periphery to the liver via reverse cholesterol transport (RCT). A critical first step in this process is the uptake of cholesterol from lipid-loaded macrophages by HDL, a function of HDL inversely associated with prevalent and incident cardiovascular disease. We hypothesized that the dynamic ability of HDL to undergo remodeling and exchange of apoA-I is an important and potentially rate-limiting aspect of RCT. In this study, we investigated the relationship between HDL-apoA-I exchange (HAE) and serum HDL cholesterol (HDL-C) efflux capacity. We compared HAE to the total and ABCA1-specific cholesterol efflux capacity of 77 subjects. We found that HAE was highly correlated with both total (r = 0.69, P < 0.0001) and ABCA1-specific (r = 0.47, P < 0.0001) efflux, and this relationship remained significant after adjustment for HDL-C or apoA-I. Multivariate models of sterol efflux capacity indicated that HAE accounted for approximately 25% of the model variance for both total and ABCA1-specific efflux. We conclude that the ability of HDL to exchange apoA-I and remodel, as measured by HAE, is a significant contributor to serum HDL efflux capacity, independent of HDL-C and apoA-I, indicating that HDL dynamics are an important factor in cholesterol efflux capacity and likely RCT.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ATP binding cassette transporter A1; high density lipoprotein; high density lipoprotein remodeling/exchange; high density lipoprotein/metabolism; lipoproteins

Mesh:

Substances:

Year:  2015        PMID: 26254308      PMCID: PMC4583080          DOI: 10.1194/jlr.M059865

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  52 in total

1.  Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages.

Authors:  Omar L Francone; Lori Royer; Germaine Boucher; Mehrdad Haghpassand; Ann Freeman; Dominique Brees; Robert J Aiello
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

2.  Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.

Authors:  Bela F Asztalos; Dorothea Collins; L Adrienne Cupples; Serkalem Demissie; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

3.  Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion.

Authors:  K A Rye; N J Hime; P J Barter
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

4.  The roles of different pathways in the release of cholesterol from macrophages.

Authors:  Maria Pia Adorni; Francesca Zimetti; Jeffrey T Billheimer; Nan Wang; Daniel J Rader; Michael C Phillips; George H Rothblat
Journal:  J Lipid Res       Date:  2007-08-29       Impact factor: 5.922

5.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

Review 6.  High-density lipoprotein function, dysfunction, and reverse cholesterol transport.

Authors:  Edward A Fisher; Jonathan E Feig; Bernd Hewing; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12       Impact factor: 8.311

7.  Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels.

Authors:  Elise F Villard; Petra EI Khoury; Eric Frisdal; Eric Bruckert; Karine Clement; Dominique Bonnefont-Rousselot; Randa Bittar; Wilfried Le Goff; Maryse Guerin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-31       Impact factor: 8.311

8.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

9.  Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Michael J Thomas; Perry L Colvin; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-17       Impact factor: 8.311

10.  Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.

Authors:  Henry J Pownall; Brian D Hosken; Baiba K Gillard; Catherine L Higgins; Hu Yu Lin; John B Massey
Journal:  Biochemistry       Date:  2007-05-27       Impact factor: 3.162

View more
  16 in total

1.  Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.

Authors:  Eric Soupene; Mark S Borja; Mauricio Borda; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2016-06-27

2.  A Novel Cell-Free Fluorescent Assay for HDL Function: Low Apolipoprotein A1 Exchange Rate Associated with Increased Incident Cardiovascular Events.

Authors:  Shuhui Wang Lorkowski; Gregory Brubaker; Lin Li; Xinmin S Li; Stanley L Hazen; Jonathan D Smith
Journal:  J Appl Lab Med       Date:  2020-05-01

3.  Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function.

Authors:  Mark A Sarzynski; Jonathan J Ruiz-Ramie; Jacob L Barber; Cris A Slentz; John W Apolzan; Robert W McGarrah; Melissa N Harris; Timothy S Church; Mark S Borja; Yumin He; Michael N Oda; Corby K Martin; William E Kraus; Anand Rohatgi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-08       Impact factor: 8.311

Review 4.  Inflammation, remodeling, and other factors affecting HDL cholesterol efflux.

Authors:  Graziella E Ronsein; Tomáš Vaisar
Journal:  Curr Opin Lipidol       Date:  2017-02       Impact factor: 4.776

Review 5.  Different Pathways of Cellular Cholesterol Efflux.

Authors:  Alexander D Dergunov; Veronika B Baserova
Journal:  Cell Biochem Biophys       Date:  2022-06-23       Impact factor: 2.989

6.  Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus.

Authors:  Robert C Block; Ashley Holub; Amir Abdolahi; Xin M Tu; Shaker A Mousa; Michael N Oda
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-09-09       Impact factor: 4.006

7.  Cholesterol Efflux and Collateral Circulation in Chronic Total Coronary Occlusion: Effect-Circ Study.

Authors:  Seonhwa Lee; Jung Mi Park; Soo-Jin Ann; Moonjong Kang; Eun Jeong Cheon; Dan Bi An; Yu Ri Choi; Chan Joo Lee; Jaewon Oh; Sungha Park; Seok-Min Kang; Sang-Hak Lee
Journal:  J Am Heart Assoc       Date:  2021-02-26       Impact factor: 5.501

8.  Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals.

Authors:  Theodoros Kelesidis; Michael N Oda; Mark S Borja; Yumin Yee; Kit F Ng; Diana Huynh; David Elashoff; Judith S Currier
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.771

9.  Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice.

Authors:  Jaume Amengual; Yoscar Ogando; Cyrus Nikain; Alexandra Quezada; Kun Qian; Tomas Vaisar; Edward A Fisher
Journal:  Mol Pharmacol       Date:  2020-12-31       Impact factor: 4.436

10.  Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease.

Authors:  Mark S Borja; Bradley Hammerson; Chongren Tang; Olga V Savinova; Gregory C Shearer; Michael N Oda
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.